ALK and lung cancer: In 2022, Naranjo et al. used genetic engineering techniques to obtain LCOs with specific Kras-, Trp53-deficient, and Eml53-Alk mutations, which significantly accelerated the study of the lung cancer genetic mechanisms (Naranjo et al., 2022).